PRKCI and neoplasm: PRKCI expression and signaling activity exhibit strong positive correlations with poor overall patient survival and an independent autophagy-driven, signature of poor PDAC patient survival, while PRKCI expression negatively correlates with multiple anti-tumor immunity pathways, providing clinical relevance to our observation that PKCι plays a promotive role in murine PDAC development.